Skip to main content

Susquehanna Portfolio Strategies, LLC

Source: SEC Form 13F · as of Mar 2026

Susquehanna Portfolio Strategies, LLC holds 75 biotech & pharma companies tracked by BioSniper, totaling $243.0M in value as of Mar 2026 (SEC Form 13F).

Companies held

75

Total value held

$243.0M

BioSniper AIPage evidence connected

Prepared research question

What matters most for INSMED Inc (INSM)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
INSMINSMED Inc207,527$33.9M
MRNAModerna, Inc.471,043$23.9M
CYTKCYTOKINETICS INC278,429$18.4M
FOLDAMICUS THERAPEUTICS, INC.1,075,323$15.5M
GILDGILEAD SCIENCES, INC.78,260$10.9M
COGTCogent Biosciences, Inc.229,755$8.8M
JAZZJazz Pharmaceuticals plc43,277$8.2M
SUPNSUPERNUS PHARMACEUTICALS, INC.142,182$7.3M
IONSIONIS PHARMACEUTICALS INC95,960$7.2M
EXELEXELIXIS, INC.159,212$6.8M
ADPTAdaptive Biotechnologies Corp374,269$5.2M
RCUSArcus Biosciences, Inc.239,966$5.2M
MLTXMoonLake Immunotherapeutics253,974$4.7M
STOKStoke Therapeutics, Inc.119,226$3.9M
ALMSALUMIS INC.172,779$3.8M
RLAYRelay Therapeutics, Inc.339,080$3.4M
CGEMCullinan Therapeutics, Inc.233,842$3.3M
BEAMBeam Therapeutics Inc.138,132$3.3M
IOVAIOVANCE BIOTHERAPEUTICS, INC.914,449$3.2M
ARVNARVINAS, INC.301,245$3.2M
VCELVericel Corp94,595$3.0M
DNLIDenali Therapeutics Inc.157,896$3.0M
GPCRStructure Therapeutics Inc.60,517$2.9M
KURAKura Oncology, Inc.343,891$2.8M
SYRESpyre Therapeutics, Inc.53,101$2.7M
BHVNBiohaven Ltd.310,647$2.6M
ZYMEZymeworks Inc.99,795$2.5M
NKTRNEKTAR THERAPEUTICS34,527$2.5M
SRRKScholar Rock Holding Corp48,184$2.4M
QUREuniQure N.V.138,969$2.3M
ANNXAnnexon, Inc.360,319$2.0M
ANABANAPTYSBIO, INC35,948$2.0M
ELVNEnliven Therapeutics, Inc.49,061$1.9M
BMRNBIOMARIN PHARMACEUTICAL INC31,809$1.8M
OLMAOlema Pharmaceuticals, Inc.113,842$1.7M
INVAInnoviva, Inc.71,995$1.7M
NRIXNurix Therapeutics, Inc.107,663$1.7M
ALNYALNYLAM PHARMACEUTICALS, INC.5,005$1.7M
LGNDLigand Pharmaceuticals Incorporated7,969$1.6M
RGNXREGENXBIO Inc.186,601$1.6M
CMPSCOMPASS Pathways plc275,773$1.5M
NTLAIntellia Therapeutics, Inc.113,904$1.5M
SLDBSolid Biosciences Inc.197,571$1.4M
DAWNDay One Biopharmaceuticals, Inc.57,379$1.2M
VRDNViridian Therapeutics, Inc.\DE52,571$1.0M
RCKTRocket Pharmaceuticals Inc.260,809$934K
PTCTPTC THERAPEUTICS, INC.13,525$921K
DNAGinkgo Bioworks Holdings Inc.126,720$777K
ROIVRoivant Sciences Ltd.27,035$749K
CLDXCelldex Therapeutics, Inc.22,180$704K
CCCCC4 Therapeutics, Inc.260,279$685K
PRTAPROTHENA CORP PUBLIC LTD CO67,870$660K
BBIOBridgeBio Pharma, Inc.7,159$532K
SANASana Biotechnology, Inc.167,503$482K
FLGTFulgent Genetics Inc.28,859$459K
XFORX4 Pharmaceuticals, Inc102,599$424K
LYELLyell Immunopharma, Inc.20,800$417K
ASMBASSEMBLY BIOSCIENCES, INC.14,100$391K
BDTXBlack Diamond Therapeutics, Inc.173,647$370K
RZLTRezolute, Inc.114,329$349K
VYGRVoyager Therapeutics, Inc.89,714$346K
SVRASavara Inc59,974$327K
BCAXBicara Therapeutics Inc.14,017$279K
FDMT4D Molecular Therapeutics, Inc.28,496$265K
AVTXAvalo Therapeutics, Inc.17,227$257K
CTMXCytomX Therapeutics, Inc.48,012$226K
KRROKorro Bio, Inc.19,125$216K
RNAAtrium Therapeutics Inc.13,110$175K
PROKPROKIDNEY CORP.97,378$174K
FLNAFilana Therapeutics Inc.100,772$170K
ORICOric Pharmaceuticals, Inc.11,373$144K
ARDXARDELYX, INC.14,396$86K
ABUSArbutus Biopharma Corp18,820$85K
CLYMClimb Bio, Inc.11,056$76K
CATXPerspective Therapeutics, Inc.12,528$52K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.